article thumbnail

Maximizing Impact Through Specialty Medication Therapy Management

PharmD Live

PharmD Lives virtual clinical pharmacists provide a proactive, AI-driven Medication Therapy Management (MTM) solution that optimizes specialty drug utilization, ensures adherence and reduces unnecessary spending.

article thumbnail

Maximizing Revenue for Physicians with Limited Resources: Challenges and Solutions

PharmD Live

Leveraging Telehealth to Expand Practice Income Telehealth technologies present a powerful opportunity to enhance care and boost revenue. Addressing Medication Challenges with Optimization Medication issues such as ADEs and nonadherence are preventable yet costly. Free up staff and physicians to focus on patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PharmD Live Releases White Paper on Pharmacist-Led Virtual Care to Maximize Shared Savings for Payviders

PharmD Live

Enhancing Care Coordination: Virtual Chronic Care Management (CCM), Remote Patient Monitoring (RPM) and Medication Therapy Management (MTM) programs improve quality metrics and revenue potential.

article thumbnail

Unlocking Heart Health: A Comprehensive Guide from Ancient History to Modern Prevention

PharmD Live

Congenital Heart Defects : Heart abnormalities present from birth, causing symptoms like fatigue, rapid breathing, or cyanosis [ Cleveland Clinic, 2023 ]. PharmD Live’s Proactive Approach At PharmD Live, we focus on prevention through Medication Therapy Management (MTM).

article thumbnail

Medication Therapy Management in geriatric

FADIC

Medication Therapy Management in geriatric Medication Therapy Management (MTM) Is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

[1] The Rome IV Diagnostic Criteria (a system developed to classify the functional gastrointestinal disorders) for chronic constipation, states that these symptoms must be present for six months or greater, and must accompany at least 25 percent of bowel movements in the last three months. pylori or low thyroid function is present. [89]

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

However, the scope and complexity of the proposed rule may present implementation challenges. Standardized templates can help eliminate ambiguities, ensuring that all essential information is presented in an accessible and user-friendly manner. 34 Finally, the NHC emphasizes the importance of empowering beneficiaries through education.